Asthma and Allergy Screening AA2000 (Cross Sectional) (AA2000)

January 26, 2021 updated by: Vibeke Backer, Bispebjerg Hospital
Asthma screening of 493 asthma patients

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Questionnaire, and testing

Study Type

Observational

Enrollment (Actual)

493

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 45 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Population based asthma study

Description

Inclusion Criteria: respiratory symptoms suggestive for asthma -

Exclusion Criteria:COPD

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
asthma and rhinitis
Screening of patients with upper and lower airway symptoms
Drug: Usual care versus primary care
RCT study
Other Names:
  • RCT study, usuar care in specialist setting (GINA and ARIA)
asthma and rhintis follow-up
same Group as screened in 2000, was followed up three years later
Drug: Usual care versus primary care
RCT study
Other Names:
  • RCT study, usuar care in specialist setting (GINA and ARIA)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ACQ
Time Frame: 2004
Questionnaire based
2004
AQLQ
Time Frame: 2004
Questionnaire based
2004

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FEV1
Time Frame: 2004
Lung function
2004

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Bispebjerg Hospital

Investigators

  • Principal Investigator: Vibeke Backer, MD, Bispebjerg Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2000

Primary Completion (Actual)

January 1, 2003

Study Completion (Actual)

January 1, 2004

Study Registration Dates

First Submitted

November 5, 2013

First Submitted That Met QC Criteria

January 26, 2021

First Posted (Actual)

January 27, 2021

Study Record Updates

Last Update Posted (Actual)

January 27, 2021

Last Update Submitted That Met QC Criteria

January 26, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • asthma and allergy screening

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Asthma

Clinical Trials on Usual care versus primary care

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe